|
시장보고서
상품코드
2148313
희귀질환 진단 시장 : 검사 유형별, 기술별, 질환 유형별, 검체 유형별, 최종사용자별, 지역별Rare Disease Diagnostics Market, By Test Type, By Technology, By Disease Type, By Sample Type, By End User, By Geography |
||||||
희귀질환 진단 시장은 2026년에 28억 6,000만 달러, 2033년까지는 71억 3,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 13.9%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 28억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 13.90% | 2033년 시장 규모 예측 : | 71억 3,000만 달러 |
희귀질환(오펀 질환이라고도 함)은 인구의 극히 일부에 영향을 미치는 질환으로, 일반적으로 미국에서는 20만 명 미만, 유럽에서는 2,000명 중 1명 미만의 비율로 발병합니다. 전 세계적으로 7,000종 이상의 희귀질환이 3억 명 이상에게 영향을 미치고 있으며, 그 대부분은 유전성 질환입니다. 본 시장은 이러한 복잡하고 다양한 질환을 식별, 진단 및 모니터링하는 데 사용되는 기술과 기법을 대상으로 합니다. 이 시장에는 유전체 시퀀싱, 바이오마커 분석, 효소 분석, 영상 진단 기술 및 차세대 시퀀싱 플랫폼이 포함됩니다.
질병에 대한 인식 제고, 유전체 기술의 발전, 제약사 및 생명공학 기업의 투자 증가, 그리고 지원적인 규제 체계가 시장 성장에 기여하고 있는 반면, 희귀질환의 복잡성과 진단까지의 과정이 길어짐에 따라 보다 신속하고 정확한 진단 솔루션의 필요성이 계속해서 강조되고 있습니다.
시장 역학
전 세계 희귀질환 진단 시장은 희귀 유전 질환에 대한 인식 제고와 조기·정확한 진단에 대한 수요 증가에 힘입어 성장하고 있습니다. 차세대 염기서열 분석(NGS), 전체 유전체 염기서열 분석, 바이오마커 분석 및 AI를 활용한 진단 기술의 발전은 분자 수준에서 질환 감지 능력을 향상시키고 진단 기간을 단축하는 데 매우 중요한 역할을 하고 있습니다. 주요 시장에서 정부의 인센티브와 유리한 규제 환경은 희귀질환 진단 분야에 대한 투자와 혁신을 더욱 촉진하고 있습니다.
그러나 시장에는 높은 검사 비용, 전문적인 진단 노하우 부족, 적절한 의료 인프라의 부재, 특히 개발도상국에서의 환자층의 현저한 분산 등 많은 제약이 존재합니다. 반면, 신생아 선별 검사 프로그램, 정밀의료 이니셔티브, 디지털 헬스 플랫폼, 환자 등록부의 확대는 조기 진단 및 전문 검사에 대한 접근성 확대를 가능하게 하는 기회를 창출하고 있으며, 신흥 시장에서 희귀질환 진단 인프라 개발에 대한 투자 증가는 향후 시장 확대를 뒷받침하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문에 걸친 잠재적 수익 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 해설했습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 희귀질환 진단 시장의 주요 기업 프로파일을 소개했습니다.
- 본 보고서에서 얻은 인사이트를 통해 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 ‘전 세계 희귀질환 진단 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 희귀질환 진단 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활한 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 희귀질환 진단 시장 : 테스트 유형별, 2021년-2033년
제5장 세계의 희귀질환 진단 시장 : 기술별, 2021년-2033년
제6장 세계의 희귀질환 진단 시장 : 질환 유형별, 2021년-2033년
제7장 세계의 희귀질환 진단 시장 : 샘플 유형별, 2021년-2033년
제8장 세계의 희귀질환 진단 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 희귀질환 진단 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.10.20Rare Disease Diagnostics Market is estimated to be valued at USD 2.86 Bn in 2026 and is expected to reach USD 7.13 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.86 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.90% | 2033 Value Projection: | USD 7.13 Bn |
Rare diseases, also known as orphan diseases, affect a small percentage of the population, usually less than 200,000 people in the U.S. or fewer than 1 in 2,000 people in Europe. In total, more than 7,000 rare diseases affect more than 300 million people worldwide, most of which are of genetic origin. The market covers the technologies and methods used to identify, confirm and monitor these complicated and heterogeneous conditions The market includes genome sequencing, biomarker analysis, enzyme assays, imaging technologies, and next-generation sequencing platforms.
Increasing disease awareness, advances in genomic technologies, rising investment by pharmaceutical and biotechnology companies, and supportive regulatory structures are contributing to market growth, while the complexity of rare diseases and extended diagnostic journeys continue to highlight the need for faster and more accurate diagnostic solutions
Market Dynamics
The global rare disease diagnostics market is driven by the increasing awareness about rare genetic conditions and the increasing demand for early and accurate diagnosis. Advances in next-generation sequencing (NGS), whole genome sequencing, biomarker analysis and AI-enabled diagnostics are playing a vital role in improving the detection of diseases at the molecular scale and reducing the diagnostic timelines. The government incentives and favorable regulatory landscape in the key markets are further supporting the investments and innovations in the area of rare disease diagnostics
However, a number of constraints are present in the market, such as high costs of testing, limited availability of specialized diagnostic expertise, the lack of adequate healthcare infrastructure and the highly fragmented patient population especially in the developing economies. Meanwhile, the expansion of newborn screening programs, precision medicine initiatives, digital health platforms, and patient registries are creating opportunities to enable earlier diagnosis and wider access to specialized testing while the increasing investments in the development of rare disease diagnostic infrastructure in emerging markets are supporting the future market expansion.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global rare disease diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Illumina, Inc., Eurofins Scientific SE, QIAGEN N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and CENTOGENE N.V.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rare disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rare disease diagnostics market
Market Segmentation
- Test Type Insights (Revenue, USD Bn, 2021 - 2033)
- Genetic Testing
- Biochemical Testing
- Molecular Diagnostics
- Imaging Diagnostics
- Others
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Sanger Sequencing
- Microarray
- Mass Spectrometry
- Immunoassays
- Others
- Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
- Neurological Disorders
- Metabolic and Endocrine Disorders
- Hematological Disorders
- Immunological Disorders
- Cardiovascular Disorders
- Genetic Cancers
- Musculoskeletal Disorders
- Others
- Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
- Blood
- Saliva
- Buccal Swab
- Urine
- Tissue
- Cerebrospinal Fluid (CSF)
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Diagnostic Laboratories
- Hospitals and Clinics
- Research and Academic Institutions
- Pharmaceutical and Biotechnology Companies
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Illumina, Inc.
- Eurofins Scientific SE
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- CENTOGENE N.V.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Rare Disease Diagnostics Market, By Test Type
- Global Rare Disease Diagnostics Market, By Technology
- Global Rare Disease Diagnostics Market, By Disease Type
- Global Rare Disease Diagnostics Market, By Sample Type
- Global Rare Disease Diagnostics Market, By End User
- Global Rare Disease Diagnostics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Test Type Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Rare Disease Diagnostics Market, By Test Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biochemical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Imaging Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Rare Disease Diagnostics Market, By Technology, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sanger Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Rare Disease Diagnostics Market, By Disease Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Metabolic and Endocrine Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Immunological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Genetic Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Rare Disease Diagnostics Market, By Sample Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Saliva
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Buccal Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cerebrospinal Fluid (CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Rare Disease Diagnostics Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Rare Disease Diagnostics Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Scientific SE
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- CENTOGENE N.V.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
